Genetic analyses, including detection of deleterious mutations, to identify carriers of BRCA2 mutation is strongly advocated as the lifetime risk of breast cancer is high (81–88%) for women carrying this mutation [5], [6]. This evidence concerns the gene BRCA2 and breast cancer.